Dr. David Dalton helped change the prescription business
Dr. David Dalton helped change the prescription business with technology to what it is now today KAAAAAAAAAAAAABOOM!
Notice both HEALTH RESOURCES INC AND PPSI MENTIONED TO WORK WITH SECURITY BIOMETRICS AS WELL!
$UNVC/MERCK/MARIMED/HARVEST/SATIVEO/AGRIMED/VA/FACEBOOK/WALMART/RITEAID/WELLNESSTELEDOC
ALL TO $5.00PLUS
https://www.businesswire.com/news/home/200402...-Strategic
Security Biometrics, Inc. Subsidiary eMedRx, Forms Exclusive Strategic Alliance With Univec
February 23, 2004 09:15 AM Eastern Standard Time
BALTIMORE & NEW YORK--(BUSINESS WIRE)--Feb. 23, 2004--Security Biometrics, Inc. (OTCBB: SBTI), a leader in biometric signature authentication solutions powered by Penflow(TM), today announced its subsidiary -eMedRx(TM) Inc, (USA), has formed a strategic alliance with Physician and Pharmaceutical Services (PPSI), a division of Univec, Inc. (OTCBB: UNVC).
This alliance offers the industry's first practical application of electronic medical prescriptions geared to eliminate fraudulent Rx's as well as medical errors due to interpretation of physician's handwriting . This increased level of scrutiny offers the prescribing physician assurances that the proper medications are being dispensed to patients and allows the patient a short duration medication to test for side effects and potential allergies. The eMedRx(TM) solution is the first system that provides an actual electronic copy of the physician's signature that can be authenticated and transmitted using advanced encryption techniques.
“ using the eMedRx(TM) Penflow(TM) solution. A similar program will be implemented in Canada.”
Tweet this
Jeff D. Maynard, President and CEO of eMedRx(TM), stated, "We are pleased to form this alliance with PPSI to create an added solution for our safe and secure electronic prescribing system. PPSI's StarterScript(TM) sample voucher system will provide our users a flexible solution to give patients a trial size for a designated quantity of medication. The voucher for the patient's trial supply is accompanied by a prescription and can be redeemed at any of the nearly 55,000 retail pharmacies utilizing the PPSI adjudication system. The voucher can be printed out using the Brother MW printer or can be sent directly to the pharmacy and will incorporate an "authenticated signature" using the eMedRx(TM) Penflow(TM) solution. A similar program will be implemented in Canada."
The eMedRx(TM) electronic medical prescription will reduce prescription errors and allow physicians to transmit legible, safe and secure prescriptions. The additional security provided by the eMedRx(TM) technology using advanced encryption techniques, will capture the physician's biometric signature for the protection of the patient's privacy and provide a secure authenticated transmission to the pharmacist.
ABOUT Univec
Founded in 1992, Univec is considered one of the leading innovators in the design and production of auto-disable safety syringes. Its patented safe syringes include the AD-Syringe (auto-disable) to prevent re-use of disposable syringes, and the Sliding-Sheath Syringe to prevent needle-stick injury to healthcare workers.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.), a division of Univec, promotes and pays for pharmaceutical products though its network of pharmacies. PPSI eliminates the need for the pharmaceutical companies to distribute actual drug samples to physicians reducing potential liability for the physician, while maintaining clinical oversight and drug interaction checks for the patient.
ABOUT eMedRx and Security Biometrics Company
Electronic Medical Prescriptions "eMedRx(TM)," a Security Biometrics Company, was created to develop an electronic prescription system that offers security and privacy for physicians, pharmacies, and patients alike. In addition to offering an electronic prescribing system with signature authentication, eMedRx(TM) offers users the StarterScript (TM) and "at the point of dispensing" coupons that can be redeemed for discounts at participating drug stores or offer patients educational materials geared to increase compliance.
Security Biometrics Inc. (OTCBB: SBTI): The Company develops markets and distributes biometric signature authentication solutions powered by Penflow(TM), a system based on proprietary patents in which signatures are validated in a quick, non-invasive accurate manner. The Penflow(TM) authentication engine views the signing process as a series of movements performed in a continuous, consistent and sequential process. The Penflow(TM) algorithm allows signature authentication by monitoring human hand movements instead of the final image.
2
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding xAI’s Vision for the Future of AI xAI is making headlines with its bold ambition to raise $15 billion, potentially valuing the company at a staggering $230 billion. This move marks a significant shift in how investments in artificial intelligence are considered. Traditionally, startup evaluations focused on immediate financial returns. However, xAI is...
Continue Reading
Wipro Forms Strategic Alliance with RELEX Solutions Wipro Limited (NYSE: WIT), a prominent player in technology services and consulting, has announced a significant strategic partnership with RELEX Solutions. This collaboration aims to leverage advanced technology in supply chain and retail planning, marking an important step in enhancing operational efficiency for their...
Continue Reading
Aker ASA Unveils Comprehensive Annual Report for 2024 Aker ASA, a prominent player in the maritime and energy sectors, is excited to share its Annual Report for 2024, showcasing not just its financial performance but also its dedication to sustainability. This document provides a robust overview of the company’s achievements and highlights significant environmental,...
Continue Reading
Transformative Power of AI in Infrastructure Management Artificial Intelligence (AI) is reshaping the way businesses operate, particularly in the realm of infrastructure management. StackGen, a trailblazer in autonomous infrastructure technology, has unveiled its groundbreaking Autonomous Infrastructure Platform. This innovative platform leverages AI agents designed to...
Continue Reading
Ensurge Micropower Successfully Completes Private Placement Ensurge Micropower ASA has announced the successful placement of its private placement, which has raised an impressive gross amount of NOK 100 million. This substantial financing comes from the allocation of 83,678,032 shares in Tranche 1, along with a conditional allocation of 27,433,079 shares in Tranche 2. All...
Continue Reading